Precision BioSciences, Inc.DTILNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank77
5Y CAGR-7.0%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
-7.0%/yr
Long-term compound
Percentile
P77
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 26.10% |
| Q3 2025 | 24.68% |
| Q2 2025 | -4.68% |
| Q1 2025 | -3.12% |
| Q4 2024 | -214.26% |
| Q3 2024 | 59.88% |
| Q2 2024 | 21.87% |
| Q1 2024 | -127.07% |
| Q4 2023 | 64.31% |
| Q3 2023 | -5.70% |
| Q2 2023 | 30.84% |
| Q1 2023 | -43.20% |
| Q4 2022 | -179.99% |
| Q3 2022 | 212.37% |
| Q2 2022 | 15.79% |
| Q1 2022 | -17.88% |
| Q4 2021 | 0.80% |
| Q3 2021 | 23.13% |
| Q2 2021 | -149.34% |
| Q1 2021 | 560.18% |
| Q4 2020 | 37.48% |
| Q3 2020 | 15.65% |
| Q2 2020 | -2.12% |
| Q1 2020 | -3.56% |
| Q4 2019 | -31.11% |
| Q3 2019 | 19.49% |
| Q2 2019 | 1.11% |
| Q1 2019 | -9.68% |
| Q4 2018 | -19.24% |
| Q3 2018 | -83.05% |
| Q2 2018 | 30.75% |
| Q1 2018 | 0.00% |